UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
[X] | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2003 |
|
OR |
|
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _______________________________ to ______________________ |
PAGE 1 OF 234 TOTAL SEQUENTIALLY NUMBERED PAGES EXHIBIT INDEX ON PAGE 140 |
|
||
|
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]
2 |
||
|
||
|
ITEM
|
|
|
PAGE
|
1.
|
Business
|
|
4-26
|
|
Executive Officers of the Company
|
|
27-28
|
|
|
|
|
2.
|
Properties
|
|
29-30
|
|
|
|
|
3.
|
Legal Proceedings
|
|
30-31
|
|
|
|
|
4.
|
Submission of Matters to a Vote of Security Holders
|
|
31
|
|
|
|
|
5.
|
Market for the Registrant's Common Stock and Related Stockholder Matters
|
|
32
|
|
|
|
|
6.
|
Selected Financial Data
|
|
33
|
|
|
|
|
7.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
34-77
|
|
|
|
|
7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
78
|
|
|
|
|
8.
|
Financial Statements and Supplementary Data
|
|
79-133
|
|
|
|
|
9.
|
Changes in and Disagreements With Accountants on Accounting
|
|
|
|
and Financial Disclosure
|
|
134
|
|
|
|
|
9A.
|
Controls and Procedures
|
|
134
|
10.
|
Directors and Executive Officers of the Registrant
|
|
135
|
|
|
|
|
11.
|
Executive Compensation
|
|
135
|
|
|
|
|
12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
135-136
|
|
|
|
|
13.
|
Certain Relationships and Related Transactions
|
|
136
|
|
|
|
|
14.
|
Auditor Fees
|
|
136
|
15.
|
Exhibits, Financial Statement Schedules, and Reports on Form 8-K
|
|
137
|
|
Signatures
|
|
138-139
|
3
|
||
|
||
|
4 |
||
|
||
|
5 |
||
|
||
|
6 |
||
|
||
|
7 |
||
|
||
|
8 |
||
|
||
|
9 |
||
|
||
|
10 |
||
|
||
|
11 |
||
|
||
|
12 |
||
|
||
|
13 |
||
|
||
|
14 |
||
|
||
|
15 |
||
|
||
|
16 |
||
|
||
|
17 |
||
|
||
|
18 |
||
|
||
|
19 |
||
|
||
|
20 |
||
|
||
|
21 |
||
|
||
|
22 |
||
|
||
|
23 |
||
|
||
|
24 |
||
|
||
|
25 |
||
|
||
|
26 |
||
|
||
|
27 |
||
|
||
|
28 |
||
|
||
|
Latin America
Zarate, Argentina
|
|
|
|
x
|
|
Cosoleacaque, Mexico
|
|
|
|
x
|
|
Uruapan, Mexico
|
x
|
|
|
|
|
29 |
||
|
||
|
30 |
||
|
||
|
31
|
||
|
||
|
32 |
||
|
||
|
33 |
||
|
||
|
34
|
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
35 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
36 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
37 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Earnings (Loss)
|
|
|
|
|
|
|
|
|
|
(Dollars in millions, except per share amounts)
|
|
2003
|
|
2002
|
|
|
|||
|
|
|
|
|
Operating earnings (loss)
|
$
|
(267)
|
$
|
208
|
Net earnings (loss) before cumulative effect of change in accounting principle
|
|
(273)
|
|
79
|
Net earnings (loss)
|
|
(270)
|
|
61
|
Earnings (loss) per share
|
|
|
|
|
--Basic
|
|
(3.50)
|
|
0.79
|
--Diluted
|
|
(3.50)
|
|
0.79
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
489
|
|
5
|
Goodwill impairments
|
|
34
|
|
--
|
Other operating income
|
|
(33)
|
|
--
|
38 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2003
|
|
2002
|
Change
|
Volume Effect
|
Price Effect
|
Product
Mix Effect
|
Exchange Rate Effect
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
$
|
5,800
|
$
|
5,320
|
9 %
|
(1) %
|
5 %
|
1 %
|
4 %
|
39 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
40 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
|
|||
Eastman Division Segments:
|
|
|
|
|
CASPI Segment:
|
|
|
|
|
Fixed asset impairments
|
$
|
195
|
$
|
2
|
Intangible asset impairments
|
|
175
|
|
--
|
Goodwill impairments
|
|
34
|
|
--
|
Severance charges
|
|
13
|
|
--
|
Site closure costs
|
|
3
|
|
3
|
|
|
|
|
|
PCI Segment:
|
|
|
|
|
Fixed asset impairments
|
|
95
|
|
(1)
|
Severance charges
|
|
4
|
|
|
|
|
|
|
|
SP Segment
|
|
|
|
|
Severance charges
|
|
1
|
|
--
|
|
|
|
|
|
|
|
|||
Total Eastman Division
|
|
520
|
|
4
|
|
|
|
|
|
Voridian Division Segments:
|
|
|
|
|
Polymers Segment:
|
|
|
|
|
Fixed asset impairments
|
|
1
|
|
1
|
Severance charges
|
|
1
|
|
--
|
|
|
|
|
|
Fibers Segment:
|
|
|
|
|
Severance charges
|
|
1
|
|
--
|
|
|
|
|
|
|
|
|||
Total Voridian Division
|
|
3
|
|
1
|
|
|
|||
|
|
|
|
|
Total Eastman Chemical Company
|
$
|
523
|
$
|
5
|
|
|
|||
|
|
|
|
|
Total asset impairments and restructuring charges, net
|
|
489
|
|
5
|
Total goodwill impairments
|
|
34
|
|
--
|
|
|
|||
|
|
|
|
|
Total Eastman Chemical Company
|
$
|
523
|
$
|
5
|
|
|
41 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
42 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
43 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
Balance at
January 1, 2002
|
|
Provision/ Adjustments
|
|
Noncash Reductions
|
|
Cash Reductions
|
|
Balance at
December 31, 2002
|
|
|
|
|
|
|
|
|
|
|
|
Noncash charges
|
$
|
--
|
$
|
2
|
$
|
(2)
|
$
|
--
|
$
|
--
|
Severance costs
|
|
10
|
|
2
|
|
--
|
|
(10)
|
|
2
|
Site closure costs
|
|
13
|
|
3
|
|
--
|
|
(9)
|
|
7
|
|
|
|
|
|
||||||
Total
|
$
|
23
|
$
|
7
|
$
|
(2)
|
$
|
(19)
|
$
|
9
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at
January 1, 2003
|
|
Provision/ Adjustments
|
|
Noncash Reductions
|
|
Cash Reductions
|
|
Balance at
December 31, 2003
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
Noncash charges
|
$
|
--
|
$
|
500
|
$
|
(500)
|
$
|
--
|
$
|
--
|
Severance costs
|
|
2
|
|
20
|
|
--
|
|
(12)
|
|
10
|
Site closure costs
|
|
7
|
|
3
|
|
--
|
|
(5)
|
|
5
|
|
|
|
|
|
||||||
Total
|
$
|
9
|
$
|
523
|
$
|
(500)
|
$
|
(17)
|
$
|
15
|
|
|
|
|
|
(Dollars in millions)
|
2003
|
|
2002
|
|
|
||
|
|
|
|
Other operating income
|
(33)
|
|
--
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Gross interest costs
|
$
|
133
|
$
|
132
|
|
|
Less: capitalized interest
|
|
3
|
|
4
|
|
|
|
|
|||||
Interest expense
|
|
130
|
|
128
|
|
2 %
|
Interest income
|
|
6
|
|
6
|
|
|
|
|
|||||
Interest expense, net
|
$
|
124
|
$
|
122
|
|
2 %
|
|
|
44 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions) |
2003 |
2002 |
|||||
|
|
||||||
Other income
|
$
|
(28)
|
$
|
(14)
|
|||
Other charges
|
|
18
|
|
16
|
|||
|
|
||||||
Other (income) charges, net
|
$
|
(10)
|
$
|
2
|
|||
|
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Provision (benefit) for income taxes
|
$
|
(108)
|
$
|
5
|
|
N/A
|
Effective tax rate
|
|
28%
|
|
5%
|
|
|
45 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
|
|||
|
|
|
|
|
Cumulative effect of change in accounting principles, net
|
$
|
3
|
$
|
(18)
|
46 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
47 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
48 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
CASPI Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
External Sales
|
$
|
1,597
|
$
|
1,540
|
|
4 %
|
Volume effect
|
|
|
|
|
|
(6) %
|
Price effect
|
|
|
|
|
|
2 %
|
Product mix effect
|
|
|
|
|
|
3 %
|
Exchange rate effect
|
|
|
|
|
|
5 %
|
|
|
|
|
|
|
|
Interdivisional sales
|
|
--
|
|
--
|
|
N/A
|
|
|
|
|
|
|
|
Operating earnings (loss)
|
|
(358)
|
|
58
|
|
N/A
|
|
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
386
|
|
5
|
|
|
Goodwill impairments
|
|
34
|
|
--
|
|
|
Other operating income
|
|
(13)
|
|
--
|
|
|
49 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
PCI Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
External Sales
|
$
|
1,184
|
$
|
1,084
|
|
9 %
|
Volume effect
|
|
|
|
|
|
-- %
|
Price effect
|
|
|
|
|
|
7 %
|
Product mix effect
|
|
|
|
|
|
-- %
|
Exchange rate effect
|
|
|
|
|
|
2 %
|
|
|
|
|
|
|
|
Interdivisional sales
|
|
495
|
|
383
|
|
29 %
|
|
|
|
|
|
|
|
Operating loss
|
|
(89)
|
|
14
|
|
N/A
|
|
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
99
|
|
(1)
|
|
|
50 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
SP Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
External Sales
|
$
|
559
|
$
|
528
|
|
6 %
|
Volume effect
|
|
|
|
|
|
1 %
|
Price effect
|
|
|
|
|
|
-- %
|
Product mix effect
|
|
|
|
|
|
1 %
|
Exchange rate effect
|
|
|
|
|
|
4 %
|
|
|
|
|
|
|
|
Interdivisional sales
|
|
49
|
|
45
|
|
9 %
|
|
|
|
|
|
|
|
Operating earnings
|
|
63
|
|
34
|
|
85 %
|
|
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
1
|
|
-
|
|
|
Other operating income
|
|
20
|
|
-
|
|
|
51 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Polymers Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
External Sales
|
$
|
1,756
|
$
|
1,510
|
|
16 %
|
Volume effect
|
|
|
|
|
|
2 %
|
Price effect
|
|
|
|
|
|
11 %
|
Product mix effect
|
|
|
|
|
|
(1) %
|
Exchange rate effect
|
|
|
|
|
|
4 %
|
|
|
|
|
|
|
|
Interdivisional sales
|
|
68
|
|
55
|
|
23 %
|
|
|
|
|
|
|
|
Operating earnings (loss)
|
|
62
|
|
35
|
|
77 %
|
|
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
2
|
|
1
|
|
|
52 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Fibers Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
External Sales
|
$
|
635
|
$
|
642
|
|
(1) %
|
Volume effect
|
|
|
|
|
|
4 %
|
Price effect
|
|
|
|
|
|
1 %
|
Product mix effect
|
|
|
|
|
|
(9) %
|
Exchange rate effect
|
|
|
|
|
|
3 %
|
|
|
|
|
|
|
|
Interdivisional sales
|
|
80
|
|
72
|
|
10 %
|
|
|
|
|
|
|
|
Operating earnings
|
|
125
|
|
133
|
|
(6) %
|
Asset impairments and restructuring charges, net
|
|
1
|
|
--
|
|
|
53 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Developing Businesses Segment
|
||||||
|
|
|
|
|
|
|
|
|
|
||||
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
External Sales
|
$
|
69
|
$
|
16
|
|
>100 %
|
|
|
|
|
|
|
|
Interdivisional sales
|
|
396
|
|
330
|
|
20 %
|
|
|
|
|
|
|
|
Operating loss
|
|
(65)
|
|
(70)
|
|
7 %
|
54 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
Change
|
|
Volume
Effect
|
|
Price Effect
|
|
Product
Mix Effect
|
|
Exchange
Rate
Effect
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States and Canada
|
$
|
3,302
|
$
|
3,040
|
|
9 %
|
|
1 %
|
|
7 %
|
|
1 %
|
|
-- %
|
Europe, Middle East, and Africa
|
|
1,368
|
|
1,170
|
|
17 %
|
|
(1) %
|
|
-- %
|
|
2 %
|
|
16 %
|
Asia Pacific
|
|
643
|
|
636
|
|
1 %
|
|
(5) %
|
|
3 %
|
|
2 %
|
|
1 %
|
Latin America
|
|
487
|
|
474
|
|
3 %
|
|
(7) %
|
|
11 %
|
|
-- %
|
|
(1) %
|
|
|
|||||||||||||
|
$
|
5,800
|
$
|
5,320
|
|
|
|
|
|
|
|
|
|
|
|
|
55 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Earnings (Loss)
|
|
|
|
|
|
|
|
|
|
(Dollars in millions, except per share amounts)
|
|
2002
|
|
2001
|
|
|
|||
|
|
|
|
|
Operating earnings (loss)
|
$
|
208
|
$
|
(120)
|
Net earnings (loss) before cumulative effect of a change in
|
|
|
|
|
accounting principle
|
|
79
|
|
(175)
|
Net earnings (loss)
|
|
61
|
|
(175)
|
Earnings (loss) per share
|
|
|
|
|
--Basic
|
|
0.79
|
|
(2.28)
|
--Diluted
|
|
0.79
|
|
(2.28)
|
|
|
|
|
|
Asset impairments and restructuring charges
|
|
5
|
|
396
|
Other operating expense
|
|
--
|
|
50
|
Other items
|
|
--
|
|
20
|
(Dollars in millions)
|
|
2002
|
|
2001
|
Change
|
Volume Effect
|
Price Effect
|
Product
Mix Effect
|
Exchange Rate Effect
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
$
|
5,320
|
$
|
5,390
|
(1)%
|
7%
|
(7)%
|
(2)%
|
1%
|
56 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Gross Profit
|
$
|
779
|
$
|
893
|
|
(13)%
|
As a percentage of sales
|
|
14.6%
|
|
16.6%
|
|
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
|
|||
Eastman Division Segments:
|
|
|
|
|
CASPI Segment:
|
|
|
|
|
Fixed asset impairments
|
$
|
2
|
$
|
59
|
Severance charges
|
|
--
|
|
8
|
Site closure costs
|
|
3
|
|
10
|
|
|
|
|
|
PCI Segment:
|
|
|
|
|
Fixed asset impairments
|
|
(1)
|
|
69
|
Severance charges
|
|
--
|
|
3
|
Site closure costs
|
|
--
|
|
1
|
|
|
|
|
|
SP Segment
|
|
|
|
|
Fixed asset impairments
|
|
--
|
|
15
|
|
|
|
|
|
Total Eastman Division
|
|
4
|
|
165
|
|
|
|
|
|
Voridian Division Segments:
|
|
|
|
|
Polymers Segment:
|
|
|
|
|
Fixed asset impairments
|
|
1
|
|
123
|
Termination of raw material supply agreement
|
|
--
|
|
108
|
|
|
|
|
|
Total Voridian Division
|
|
1
|
|
231
|
|
|
|
|
|
|
|
|||
Total Eastman Chemical Company
|
$
|
5
|
$
|
396
|
|
|
57 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
58 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
59 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
|
|||
|
|
|
|
|
Other operating expense
|
$
|
--
|
$
|
50
|
|
|
60 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Gross interest costs
|
$
|
132
|
$
|
151
|
|
|
Less: capitalized interest
|
|
4
|
|
5
|
|
|
|
|
|||||
Interest expense
|
|
128
|
|
146
|
|
(12)%
|
Interest income
|
|
6
|
|
6
|
|
|
|
|
|||||
Interest expense, net
|
$
|
122
|
$
|
140
|
|
(13)%
|
|
|
(dollars in millions)
|
|
2002
|
|
2001
|
|
|
|||
|
|
|
|
|
Other Income
|
$
|
(14)
|
$
|
(11)
|
Other Charges
|
|
16
|
|
42
|
|
|
|||
Other (Income) Charges, net
|
$
|
2
|
$
|
31
|
|
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Provision (benefit) for income taxes
|
$
|
5
|
$
|
(116)
|
|
N/A
|
Effective tax rate
|
|
5.4%
|
|
39.8%
|
|
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
|
|||
|
|
|
|
|
Cumulative effect of change in accounting principle, net
|
$
|
(18)
|
$
|
--
|
CASPI Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Sales
|
$
|
1,540
|
$
|
1,508
|
|
2 %
|
Operating earnings (loss)
|
|
58
|
|
(25)
|
|
N/A
|
|
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
5
|
|
77
|
|
|
Other operating expense
|
|
-
|
|
11
|
|
|
62 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
PCI Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Sales
|
$
|
1,467
|
$
|
1,132
|
|
30 %
|
Operating earnings (loss)
|
|
14
|
|
(60)
|
|
N/A
|
|
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
(1)
|
|
73
|
|
|
Other operating expense
|
|
--
|
|
7
|
|
|
63 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
SP Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Sales
|
$
|
573
|
$
|
535
|
|
7 %
|
Operating earnings
|
|
34
|
|
51
|
|
(33)%
|
|
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
-
|
|
15
|
|
|
Other operating expense
|
|
-
|
|
4
|
|
|
Polymers Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Sales
|
$
|
1,565
|
$
|
1,587
|
|
(1)%
|
Operating earnings (loss)
|
|
35
|
|
(187)
|
|
N/A
|
|
|
|
|
|
|
|
Asset impairments and restructuring charges, net
|
|
1
|
|
231
|
|
|
Other operating expense
|
|
-
|
|
26
|
|
|
64 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
|
|
||||
|
|
|
|
|
|
|
Sales
|
$
|
346
|
$
|
110
|
|
>100 %
|
Operating earnings (loss)
|
|
(70)
|
|
(46)
|
|
(52) %
|
|
|
|
|
|
|
|
65 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
2002
|
|
2001
|
|
Change
|
|
Volume
Effect
|
|
Price Effect
|
|
Product
Mix Effect
|
|
Exchange
Rate
Effect
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States and Canada
|
$
|
3,040
|
$
|
3,202
|
|
(5)%
|
|
4 %
|
|
(6)%
|
|
(3)%
|
|
0 %
|
Europe, Middle East, and Africa
|
|
1,170
|
|
1,148
|
|
2 %
|
|
5 %
|
|
(7)%
|
|
0 %
|
|
4 %
|
Asia Pacific
|
|
636
|
|
555
|
|
15 %
|
|
20 %
|
|
(5)%
|
|
0 %
|
|
0 %
|
Latin America
|
|
474
|
|
485
|
|
(2)%
|
|
12 %
|
|
(13)%
|
|
1 %
|
|
(2)%
|
|
|
|||||||||||||
|
$
|
5,320
|
$
|
5,390
|
|
|
|
|
|
|
|
|
|
|
|
|
66 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
67 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
68 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
(Dollars in millions)
|
|
Payments Due For
|
||||||||||
Period
|
|
Notes and Debentures
|
|
Commercial Paper and Other Borrowings
|
|
Purchase Obligations
|
|
Operating Leases
|
|
Other Liabilities (a)
|
|
Total
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
2004
|
$
|
504
|
$
|
--
|
$
|
246
|
$
|
45
|
$
|
64
|
$
|
859
|
2005
|
|
--
|
|
196
|
|
246
|
|
40
|
|
128
|
|
610
|
2006
|
|
5
|
|
--
|
|
243
|
|
33
|
|
180
|
|
461
|
2007
|
|
--
|
|
--
|
|
240
|
|
24
|
|
151
|
|
415
|
2008
|
|
250
|
|
--
|
|
140
|
|
13
|
|
107
|
|
510
|
2009 and beyond
|
|
1,638
|
|
--
|
|
902
|
|
40
|
|
560
|
|
3,140
|
|
|
|
|
|
|
|||||||
Total
|
$
|
2,397
|
$
|
196
|
$
|
2,017
|
$
|
195
|
$
|
1,190
|
$
|
5,995
|
|
|
|
|
|
|
70 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
71 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
72 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
73 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
74 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
75 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
76 |
||
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
77 |
||
|
||
|
78 |
||
|
||
|
ITEM
|
Page
|
|
|
Management's Responsibility for Financial Statements
|
80
|
|
|
Report of Independent Auditors
|
81
|
|
|
Consolidated Statements of Earnings (Loss), Comprehensive Income (Loss) and Retained Earnings
|
82
|
|
|
Consolidated Statements of Financial Position
|
83
|
|
|
Consolidated Statements of Cash Flows
|
84
|
|
|
Notes to Consolidated Financial Statements
|
85-133
|
|
|
Financial Statement Schedules:
II - Valuation and Qualifying Accounts
|
145
|
79 |
||
|
||
|
/s/ J. Brian Ferguson
|
|
/s/ Richard A. Lorraine
|
||
|
|
|||
J. Brian Ferguson
|
|
Richard A. Lorraine
|
||
Chairman of the Board and
|
|
Senior Vice President and
|
||
|
Chief Executive Officer
|
|
|
Chief Financial Officer
|
|
|
|
|
|
March 5, 2004
|
|
|
|
80 |
||
|
||
|
/s/ PricewaterhouseCoopers LLP
|
|
81 |
||
|
||
|
|
For years ended December 31,
|
|||||
(Dollars in millions, except per share amounts)
|
|
2003
|
|
2002
|
|
2001
|
|
|
|
||||
Earnings (Loss)
|
|
|
|
|
|
|
Sales
|
$
|
5,800
|
$
|
5,320
|
$
|
5,390
|
Cost of sales
|
|
4,990
|
|
4,541
|
|
4,497
|
|
|
|
||||
Gross profit
|
|
810
|
|
779
|
|
893
|
|
|
|
|
|
|
|
Selling and general administrative expenses
|
|
414
|
|
407
|
|
407
|
Research and development expenses
|
|
173
|
|
159
|
|
160
|
Asset impairments and restructuring charges, net
|
|
489
|
|
5
|
|
396
|
Goodwill impairments
|
|
34
|
|
--
|
|
--
|
Other operating income
|
|
(33)
|
|
--
|
|
--
|
Other operating expense
|
|
--
|
|
--
|
|
50
|
|
|
|
||||
Operating earnings (loss)
|
|
(267)
|
|
208
|
|
(120)
|
|
|
|
|
|
|
|
Interest expense, net
|
|
124
|
|
122
|
|
140
|
Other (income) charges, net
|
|
(10)
|
|
2
|
|
31
|
Earnings (loss) before income taxes and cumulative effect of change in accounting principles
|
|
(381)
|
|
84
|
|
(291)
|
Provision (benefit) for income taxes
|
|
(108)
|
|
5
|
|
(116)
|
|
|
|
||||
|
|
|
|
|
|
|
Earnings (loss) before cumulative effect of change in accounting principles
|
|
(273)
|
|
79
|
|
(175)
|
Cumulative effect of change in accounting principles, net
|
|
3
|
|
(18)
|
|
--
|
|
|
|
||||
Net earnings (loss)
|
$
|
(270)
|
$
|
61
|
$
|
(175)
|
|
|
|
||||
|
|
|
|
|
|
|
Earnings (loss) per share
|
|
|
|
|
|
|
Basic
|
|
|
|
|
|
|
Before cumulative effect of change in accounting principles
|
$
|
(3.54)
|
$
|
1.02
|
$
|
(2.28)
|
Cumulative effect of change in accounting principles, net
|
|
0.04
|
|
(0.23)
|
|
--
|
|
|
|
||||
Net earnings (loss) per share
|
$
|
(3.50)
|
$
|
0.79
|
$
|
(2.28)
|
|
|
|
||||
|
|
|
|
|
|
|
Diluted
|
|
|
|
|
|
|
Before cumulative effect of change in accounting principles
|
$
|
(3.54)
|
$
|
1.02
|
$
|
(2.28)
|
Cumulative effect of change in accounting principles, net
|
|
0.04
|
|
(0.23)
|
|
--
|
|
|
|
||||
Net earnings (loss) per share
|
$
|
(3.50)
|
$
|
0.79
|
$
|
(2.28)
|
|
|
|
||||
|
|
|
|
|
|
|
Comprehensive Income (Loss)
|
|
|
|
|
|
|
Net earnings (loss)
|
$
|
(270)
|
$
|
61
|
$
|
(175)
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
Change in cumulative translation adjustment
|
|
150
|
|
102
|
|
(24)
|
Change in minimum pension liability, net of tax
|
|
19
|
|
(145)
|
|
(106)
|
Change in unrealized gains (losses) on investments, net of tax
|
|
--
|
|
(2)
|
|
(2)
|
Change in unrealized gains (losses) on derivative instruments, net of tax
|
|
5
|
|
1
|
|
(2)
|
|
|
|
||||
Total other comprehensive income (loss)
|
|
174
|
|
(44)
|
|
(134)
|
|
|
|
||||
Comprehensive income (loss)
|
$
|
(96)
|
$
|
17
|
$
|
(309)
|
|
|
|
||||
|
|
|
|
|
|
|
Retained Earnings
|
|
|
|
|
|
|
Retained earnings at beginning of period
|
$
|
1,882
|
$
|
1,956
|
$
|
2,266
|
Net earnings (loss)
|
|
(270)
|
|
61
|
|
(175)
|
Cash dividends declared
|
|
(136)
|
|
(135)
|
|
(135)
|
|
|
|
||||
Retained earnings at end of period
|
$
|
1,476
|
$
|
1,882
|
$
|
1,956
|
|
|
|
82 |
||
|
||
|
(Dollars in millions, except per share amounts)
|
December 31,
|
|||
Assets
|
|
2003
|
|
2002
|
|
|
|||
Current assets
|
|
|
|
|
Cash and cash equivalents
|
$
|
558
|
$
|
77
|
Trade receivables, net of allowance of $28 and $32
|
|
614
|
|
532
|
Miscellaneous receivables
|
|
87
|
|
142
|
Inventories
|
|
698
|
|
713
|
Other current assets
|
|
53
|
|
83
|
|
|
|||
Total current assets
|
|
2,010
|
|
1,547
|
|
|
|||
|
|
|
|
|
Properties
|
|
|
|
|
Properties and equipment at cost
|
|
9,861
|
|
9,660
|
Less: Accumulated depreciation
|
|
6,442
|
|
5,907
|
|
|
|||
Net properties
|
|
3,419
|
|
3,753
|
|
|
|||
|
|
|
|
|
Goodwill
|
|
317
|
|
344
|
Other intangibles, net of accumulated amortization of $218 and $51
|
|
33
|
|
229
|
Other noncurrent assets
|
|
451
|
|
414
|
|
|
|||
Total assets
|
$
|
6,230
|
$
|
6,287
|
|
|
|||
|
|
|
|
|
Liabilities and Stockholders Equity
|
|
|
|
|
Current liabilities
|
|
|
|
|
Payables and other current liabilities
|
$
|
973
|
$
|
1,244
|
Borrowings due within one year
|
|
504
|
|
3
|
|
|
|||
Total current liabilities
|
|
1,477
|
|
1,247
|
|
|
|||
|
|
|
|
|
Long-term borrowings
|
|
2,089
|
|
2,054
|
Deferred income tax liabilities
|
|
316
|
|
464
|
Postemployment obligations
|
|
1,126
|
|
1,069
|
Other long-term liabilities
|
|
179
|
|
182
|
|
|
|||
Total liabilities
|
|
5,187
|
|
5,016
|
|
|
|||
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
Stockholders equity
|
|
|
|
|
Common stock ($0.01 par value 350,000,000 shares authorized; shares
issued 85,177, 467 and 85,135,117)
|
|
1
|
|
1
|
Additional paid-in capital
|
|
122
|
|
119
|
Retained earnings
|
|
1,476
|
|
1,882
|
Accumulated other comprehensive loss
|
|
(121)
|
|
(295)
|
|
|
|||
|
|
1,478
|
|
1,707
|
Less: Treasury stock at cost (7,933,646 shares for 2003 and 2002)
|
|
435
|
|
436
|
|
|
|||
|
|
|
|
|
Total stockholders equity
|
|
1,043
|
|
1,271
|
|
|
|||
|
|
|
|
|
Total liabilities and stockholders equity
|
$
|
6,230
|
$
|
6,287
|
|
|
83 |
||
|
||
|
|
For years ended December 31,
|
|||||
(Dollars in millions)
|
|
2003
|
|
2002
|
|
2001
|
|
|
|
||||
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
|
|
|
|
Net earnings (loss)
|
$
|
(270)
|
$
|
61
|
$
|
(175)
|
|
|
|
||||
|
|
|
|
|
|
|
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities, net of effect of acquisitions
|
|
|
|
|
|
|
Depreciation and amortization
|
|
367
|
|
397
|
|
435
|
Cumulative effect of change in accounting principles, net
|
|
(3)
|
|
18
|
|
--
|
Asset impairments
|
|
500
|
|
9
|
|
373
|
Gains on sale of assets
|
|
(33)
|
|
--
|
|
--
|
Write-off of acquired in-process research and development
|
|
--
|
|
--
|
|
5
|
Provision (benefit) for deferred income taxes
|
|
(140)
|
|
95
|
|
(78)
|
Changes in operating assets and liabilities, net of effect of acquisitions
|
|
|
|
|
|
|
(Increase) decrease in trade receivables
|
|
(46)
|
|
70
|
|
79
|
(Increase) decrease in inventories
|
|
41
|
|
(41)
|
|
(8)
|
Increase (decrease) in trade payables
|
|
(2)
|
|
87
|
|
(122)
|
Increase (decrease) in liabilities for employee benefits and incentive pay
|
|
(214)
|
|
81
|
|
(8)
|
Other items, net
|
|
44
|
|
24
|
|
(104)
|
|
|
|
||||
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
244
|
|
801
|
|
397
|
|
|
|
||||
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
Additions to properties and equipment
|
|
(230)
|
|
(427)
|
|
(234)
|
Proceeds from sale of assets
|
|
71
|
|
9
|
|
4
|
Acquisitions, net of cash acquired
|
|
--
|
|
(6)
|
|
(257)
|
Additions to capitalized software
|
|
(15)
|
|
(18)
|
|
(28)
|
Other items, net
|
|
14
|
|
(25)
|
|
(8)
|
|
|
|
||||
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
(160)
|
|
(467)
|
|
(523)
|
|
|
|
||||
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
Net increase (decrease) in commercial paper and other short-term borrowings
|
|
39
|
|
(573)
|
|
221
|
Proceeds from long-term borrowings
|
|
495
|
|
394
|
|
--
|
Repayment of borrowings
|
|
(5)
|
|
(8)
|
|
(11)
|
Dividends paid to stockholders
|
|
(136)
|
|
(135)
|
|
(135)
|
Other items
|
|
4
|
|
(1)
|
|
16
|
|
|
|
||||
Net cash provided by (used in) financing activities
|
|
397
|
|
(323)
|
|
91
|
|
|
|
||||
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
481
|
|
11
|
|
(35)
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period
|
|
77
|
|
66
|
|
101
|
|
|
|
||||
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
$
|
558
|
$
|
77
|
$
|
66
|
|
|
|
84
|
||
|
||
|
1. SIGNIFICANT ACCOUNTING POLICIES
85 |
||
|
||
|
86 |
||
|
||
|
87 |
||
|
||
|
88 |
||
|
||
|
89 |
||
|
||
|
90 |
||
|
||
|
|
December 31
|
|||
(Dollars in millions)
|
|
2003
|
|
2002
|
|
|
|||
|
|
|
|
|
At FIFO or average cost (approximates current cost)
|
|
|
|
|
Finished goods
|
$
|
583
|
$
|
582
|
Work in process
|
|
175
|
|
175
|
Raw materials and supplies
|
|
228
|
|
229
|
|
|
|||
Total inventories
|
|
986
|
|
986
|
Reduction to LIFO value
|
|
(288)
|
|
(273)
|
|
|
|||
Total inventories at LIFO value
|
$
|
698
|
$
|
713
|
|
|
91 |
||
|
||
|
|
December 31
|
|||
(Dollars in millions)
|
|
2003
|
|
2002
|
|
|
|||
Properties at Cost
|
|
|
|
|
Balance at beginning of year
|
$
|
9,660
|
$
|
9,302
|
Additions
|
|
|
|
|
Capital expenditures
|
|
230
|
|
427
|
Deductions
|
|
(29)
|
|
(69)
|
|
|
|||
Balance at end of year
|
$
|
9,861
|
$
|
9,660
|
|
|
|||
|
|
|
|
|
Properties
|
|
|
|
|
Land
|
$
|
77
|
$
|
73
|
Buildings and building equipment
|
|
953
|
|
920
|
Machinery and equipment
|
|
8,710
|
|
8,483
|
Construction in progress
|
|
121
|
|
184
|
|
|
|||
Balance at end of year
|
$
|
9,861
|
$
|
9,660
|
|
|
|||
|
|
|
|
|
Accumulated Depreciation
|
|
|
|
|
Balance at beginning of year
|
$
|
5,907
|
$
|
5,675
|
Provision for depreciation
|
|
334
|
|
358
|
Fixed asset impairments
|
|
291
|
|
4
|
Deductions
|
|
(90)
|
|
(130)
|
|
|
|||
Balance at end of year
|
$
|
6,442
|
$
|
5,907
|
|
|
92 |
||
|
||
|
93 |
||
|
||
|
94 |
||
|
||
|
|
December 31
|
|||
(Dollars in millions)
|
|
2003
|
|
2002
|
|
|
|||
|
|
|
|
|
Trade creditors
|
$
|
478
|
$
|
471
|
Accrued payrolls, vacation, and variable-incentive compensation
|
|
135
|
|
194
|
Accrued taxes
|
|
63
|
|
61
|
Interest payable
|
|
45
|
|
48
|
Current portion of U.S. defined benefit pension plan liabilities
|
|
--
|
|
220
|
Bank overdrafts
|
|
22
|
|
39
|
Other
|
|
230
|
|
211
|
|
|
|||
Total
|
$
|
973
|
$
|
1,244
|
|
|
|
December 31
|
|||
(Dollars in millions)
|
2003
|
|
2002
|
|
|
|
|||
|
|
|
|
|
Borrowings consisted of:
|
|
|
|
|
6 3/8% notes due 2004
|
$
|
504
|
$
|
513
|
3 1/4% notes due 2008
|
250
|
|
--
|
|
6.30% notes due 2018
|
249
|
|
--
|
|
7% notes due 2012
|
394
|
|
397
|
|
7 1/4% debentures due 2024
|
496
|
|
496
|
|
7 5/8% debentures due 2024
|
200
|
|
200
|
|
7.60% debentures due 2027
|
297
|
|
297
|
|
Commercial paper borrowings
|
196
|
|
143
|
|
Other
|
7
|
|
11
|
|
|
|
|||
Total borrowings
|
2,593
|
|
2,057
|
|
Borrowings due within one year
|
(504)
|
|
(3)
|
|
|
|
|||
Long-term borrowings
|
$
|
2,089
|
$
|
2,054
|
|
|
95 |
||
|
||
|
96 |
||
|
||
|
December 31, 2003 | December 31, 2002 | ||||||||
|
|
||||||||
(Dollars in millions)
|
|
Recorded Amount
|
|
Fair Value
|
|
Recorded
Amount
|
|
Fair Value
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
Long-term borrowings
|
$
|
2,089
|
$
|
2,247
|
$
|
2,054
|
$
|
2,220
|
97 |
||
|
||
|
98 |
||
|
||
|
99 |
||
|
||
|
100 |
||
|
||
|
101 |
||
|
||
|
Weighted-average assumptions used to determine end of year net benefit cost:
|
2003
|
|
2002
|
|
2001
|
|
|
|
|||
|
|
|
|
|
|
Discount rate
|
6.75%
|
|
7.25%
|
|
7.75%
|
Rate of compensation increase
|
4.00%
|
|
4.00%
|
|
4.25%
|
Health care cost trend
|
|
|
|
|
|
Initial
|
10.00%
|
|
10.00%
|
|
7.00%
|
Decreasing to ultimate trend of
|
5.25%
|
|
5.00%
|
|
5.00%
|
In year
|
2007
|
|
2006
|
|
2006
|
102 |
||
|
||
|
103 |
||
|
||
|
(Dollars in millions)
|
|
Payments Due For
|
||||||||
|
||||||||||
Period
|
|
Notes and Debentures
|
|
Commercial Paper and Other Borrowings
|
|
Purchase Obligations
|
|
Operating Leases
|
|
Total
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
2004
|
$
|
504
|
$
|
--
|
$
|
246
|
$
|
45
|
$
|
795
|
2005
|
|
--
|
|
196
|
|
246
|
|
40
|
|
482
|
2006
|
|
5
|
|
--
|
|
243
|
|
33
|
|
281
|
2007
|
|
--
|
|
--
|
|
240
|
|
24
|
|
264
|
2008
|
|
250
|
|
--
|
|
140
|
|
13
|
|
403
|
2009-2013
|
|
396
|
|
--
|
|
643
|
|
29
|
|
1,068
|
Beyond 2013
|
|
1,242
|
|
--
|
|
259
|
|
11
|
|
1,512
|
|
|
|
|
|
||||||
Total
|
$
|
2,397
|
$
|
196
|
$
|
2,017
|
$
|
195
|
$
|
4,805
|
|
|
|
|
|
104 |
||
|
||
|
(Dollars in millions)
|
|
|
|
|
|
Obligations of equity affiliates
|
$
|
131
|
Residual value guarantees
|
|
93
|
|
||
Total
|
$
|
224
|
|
105 |
||
|
||
|
106 |
||
|
||
|
107 |
||
|
||
|
(Dollars in millions)
|
|
Cumulative Translation Adjustment
|
|
Unfunded Minimum Pension
Liability
|
|
Unrealized
Gains
(Losses) on Investments
|
|
Unrealized
Gains
(Losses) on
Cash Flow
Hedges
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2001
|
$
|
(133)
|
$
|
(116)
|
$
|
--
|
$
|
(2)
|
$
|
(251)
|
Period change
|
|
102
|
|
(145)
|
|
(2)
|
|
1
|
|
(44)
|
|
|
|
|
|
||||||
Balance at December 31, 2002
|
|
(31)
|
|
(261)
|
|
(2)
|
|
(1)
|
|
(295)
|
Period change
|
|
150
|
|
19
|
|
--
|
|
5
|
|
174
|
|
|
|
|
|
||||||
Balance at December 31, 2003
|
$
|
119
|
$
|
(242)
|
$
|
(2)
|
$
|
4
|
$
|
(121)
|
|
|
|
|
|
108 |
||
|
||
|
109 |
||
|
||
|
110 |
||
|
||
|
111 |
||
|
||
|
112 |
||
|
||
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
2001
|
|
|
|
||||
Eastman Division Segments:
|
|
|
|
|
|
|
Coatings, Adhesives, Specialty Polymers, and Inks ("CASPI") Segment:
|
|
|
|
|
|
|
Fixed asset impairments
|
$
|
195
|
$
|
2
|
$
|
59
|
Intangible asset impairments
|
|
175
|
|
--
|
|
--
|
Goodwill impairments
|
|
34
|
|
--
|
|
--
|
Severance charges
|
|
13
|
|
--
|
|
8
|
Site closure costs
|
|
3
|
|
3
|
|
10
|
|
|
|
|
|
|
|
Performance Chemicals and Intermediates ("PCI") Segment:
|
|
|
|
|
|
|
Fixed asset impairments
|
|
95
|
|
(1)
|
|
69
|
Severance charges
|
|
4
|
|
--
|
|
3
|
Site closure costs
|
|
--
|
|
--
|
|
1
|
|
|
|
|
|
|
|
Specialty Plastics ("SP") Segment
|
|
|
|
|
|
|
Fixed asset impairments
|
|
--
|
|
--
|
|
15
|
Severance charges
|
|
1
|
|
--
|
|
--
|
|
|
|
||||
|
|
|
|
|
|
|
Total Eastman Division
|
|
520
|
|
4
|
|
165
|
|
|
|
|
|
|
|
Voridian Division Segments:
|
|
|
|
|
|
|
Polymers Segment:
|
|
|
|
|
|
|
Fixed asset impairments
|
|
1
|
|
1
|
|
123
|
Severance charges
|
|
1
|
|
--
|
|
--
|
Termination of raw material supply agreement
|
|
--
|
|
--
|
|
108
|
|
|
|
|
|
|
|
Fibers Segment:
|
|
|
|
|
|
|
Severance charges
|
|
1
|
|
--
|
|
--
|
|
|
|
||||
|
|
|
|
|
|
|
Total Voridian Division
|
|
3
|
|
1
|
|
231
|
|
|
|
||||
|
|
|
|
|
|
|
Total Eastman Chemical Company
|
$
|
523
|
$
|
5
|
$
|
396
|
|
|
|
||||
|
|
|
|
|
|
|
Total asset impairments and restructuring charges, net
|
|
489
|
|
5
|
|
396
|
Total goodwill impairments
|
|
34
|
|
--
|
|
--
|
|
|
|
||||
|
|
|
|
|
|
|
Total Eastman Chemical Company
|
$
|
523
|
$
|
5
|
$
|
396
|
|
|
|
113 |
||
|
||
|
114 |
||
|
||
|
115 |
||
|
||
|
116 |
||
|
||
|
117 |
||
|
||
|
(Dollars in millions)
|
2003
|
|
2002
|
|
2001
|
|
|
|
|||
|
|
|
|
|
|
Other operating income
|
(33)
|
|
--
|
|
--
|
Other operating expense
|
--
|
|
--
|
|
50
|
118 |
||
|
||
|
2003
2002
2001
(Dollars in millions)
119 |
||
|
||
|
120 |
||
|
||
|
(Dollars in millions)
|
|
2003
|
|
2002
|
|
2001
|
|
|
|
||||
|
|
|
|
|
|
|
Earnings (loss) before income taxes
|
|
|
|
|
|
|
United States
|
$
|
(309)
|
$
|
98
|
$
|
(293)
|
Outside the United States
|
|
(72)
|
|
(14)
|
|
2
|
|
|
|
||||
Total
|
$
|
(381)
|
$
|
84
|
$
|
(291)
|
|
|
|
||||
|
|
|
|
|
|
|
Provision (benefit) for income taxes
|
|
|
|
|
|
|
United States
|
|
|
|
|
|
|
Current
|
$
|
16
|
$
|
(113)
|
$
|
(44)
|
Deferred
|
|
(102)
|
|
100
|
|
(68)
|
Non-United States
|
|
|
|
|
|
|
Current
|
|
10
|
|
16
|
|
9
|
Deferred
|
|
(29)
|
|
(7)
|
|
(3)
|
State and other
|
|
|
|
|
|
|
Current
|
|
3
|
|
7
|
|
(3)
|
Deferred
|
|
(6)
|
|
2
|
|
(7)
|
|
|
|
||||
Total
|
$
|
(108)
|
$
|
5
|
$
|
(116)
|
|
|
|
121 |
||
|
||
|
122 |
||
|
||
|
(Dollars in millions)
|
2003
|
|
2002
|
|
2001
|
|
|
|
|
||||
|
|
|
|
|
|
|
Cash paid for interest and income taxes is as follows:
|
|
|
|
|
|
|
Interest (net of amounts capitalized)
|
$ |
133
|
$
|
125
|
$
|
152
|
Income taxes paid (received)
|
(43)
|
|
(40)
|
|
(7)
|
|
The Companys portion of earnings from its equity investments included in cash flows from operating activities
|
12
|
|
11
|
|
6
|
123 |
||
|
||
|
124 |
||
|
||
|
(Dollars in millions)
|
|
2003
|
||||
|
||||||
|
|
|
|
|
|
|
Sales by Division and Segment
|
|
External Sales
|
|
Interdivisional Sales
|
|
Total Sales
|
Eastman Division Segments
|
|
|
|
|
|
|
CASPI Segment
|
$
|
1,597
|
$
|
--
|
$
|
1,597
|
PCI Segment
|
|
1,184
|
|
495
|
|
1,679
|
SP segment
|
|
559
|
|
49
|
|
608
|
|
|
|
||||
Total
|
|
3,340
|
|
544
|
|
3,884
|
|
|
|
||||
|
|
|
|
|
|
|
Voridian Division Segments
|
|
|
|
|
|
|
Polymers
|
|
1,756
|
|
68
|
|
1,824
|
Fibers
|
|
635
|
|
80
|
|
715
|
|
|
|
||||
Total
|
|
2,391
|
|
148
|
|
2,539
|
|
|
|
||||
|
|
|
|
|
|
|
Developing Businesses Division
|
|
|
|
|
|
|
Developing Businesses
|
|
69
|
|
396
|
|
465
|
|
|
|
||||
Total
|
|
69
|
|
396
|
|
465
|
|
|
|
||||
|
|
|
|
|
|
|
Total Eastman Chemical Company
|
$
|
5,800
|
$
|
1,088
|
$
|
6,888
|
|
|
|
(Dollars in millions)
|
|
2002
|
||||
|
||||||
|
|
|
|
|
|
|
Sales by Division and Segment
|
|
External Sales
|
|
Interdivisional Sales
|
|
Total Sales
|
Eastman Division Segments
|
|
|
|
|
|
|
CASPI Segment
|
$
|
1,540
|
$
|
--
|
$
|
1,540
|
PCI Segment
|
|
1,084
|
|
383
|
|
1,467
|
SP segment
|
|
528
|
|
45
|
|
573
|
|
|
|
||||
Total
|
|
3,152
|
|
428
|
|
3,580
|
|
|
|
||||
|
|
|
|
|
|
|
Voridian Division Segments
|
|
|
|
|
|
|
Polymers
|
|
1,510
|
|
55
|
|
1,565
|
Fibers
|
|
642
|
|
72
|
|
714
|
|
|
|
||||
Total
|
|
2,152
|
|
127
|
|
2,279
|
|
|
|
||||
|
|
|
|
|
|
|
Developing Businesses Division
|
|
|
|
|
|
|
Developing Businesses
|
|
16
|
|
330
|
|
346
|
|
|
|
||||
Total
|
|
16
|
|
330
|
|
346
|
|
|
|
||||
|
|
|
|
|
|
|
Total Eastman Chemical Company
|
$
|
5,320
|
$
|
885
|
$
|
6,205
|
|
|
|
125 |
||
|
||
|
126 |
||
|
||
|
127 |
||
|
||
|
(Dollars in millions, except per share amounts)
|
|
First Quarter
|
|
Second Quarter
|
|
Third Quarter
|
|
Fourth Quarter
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
2003
|
|
|
|
|
|
|
|
|
Sales
|
$
|
1, 441
|
$
|
1, 481
|
$
|
1, 444
|
$
|
1,434
|
Gross profit
|
|
184
|
|
241
|
|
200
|
|
185
|
Asset impairments and restructuring charges
|
|
2
|
|
16
|
|
462
|
|
9
|
Goodwill impairments
|
|
--
|
|
--
|
|
34
|
|
--
|
Other operating income
|
|
(20)
|
|
--
|
|
--
|
|
(13)
|
Operating earnings (loss)
|
|
59
|
|
75
|
|
(440)
|
|
39
|
Earnings (loss) before income taxes and cumulative effect of change in accounting principles
|
|
29
|
|
49
|
|
(471)
|
|
12
|
Provision (benefit) for income taxes
|
|
11
|
|
14
|
|
(135)
|
|
2
|
Earnings (loss) before cumulative effect of change in accounting principles
|
|
18
|
|
35
|
|
(336)
|
|
10
|
Cumulative effect of change in accounting principles, net
|
|
3
|
|
--
|
|
--
|
|
--
|
Net earnings (loss)
|
|
21
|
|
35
|
|
(336)
|
|
10
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
|
|
|
|
Earnings (loss) per share before cumulative effect of change in accounting principles
|
$
|
0.23
|
$
|
0.46
|
$
|
(4.35)
|
$
|
0.13
|
Cumulative effect of change in accounting principles, net
|
|
0.04
|
|
--
|
|
--
|
|
--
|
|
|
|
|
|||||
Net earnings (loss) per share
(2)
|
$
|
0.27
|
$
|
0.46
|
$
|
(4.35)
|
$
|
0.13
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
|
|
|
|
|
|
Earnings (loss) per share before cumulative effect of change in accounting principles
|
$
|
0.23
|
$
|
0.46
|
$
|
(4.35)
|
$
|
0.13
|
Cumulative effect of change in accounting principles, net
|
|
0.04
|
|
--
|
|
--
|
|
--
|
|
|
|
|
|||||
Net earnings (loss) per share
(2)
|
$
|
0.27
|
$
|
0.46
|
$
|
(4.35)
|
$
|
0.13
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
128 |
||
|
||
|
(1) Results for the first quarter 2002 included a $5 million charge related to the previously announced restructuring of Genencor.
129 |
||
|
||
|
130 |
||
|
||
|
131 |
||
|
||
|
132 |
||
|
||
|
133 |
||
|
||
|
134 |
||
|
||
|
135 |
||
|
||
|
Plan Category
|
|
Number of Securities to be Issued upon Exercise of Outstanding Options
(a)
|
|
Weighted-Average Exercise Price of Outstanding Options
(b)
|
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding securities reflected in Column (a))
(c)
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
Equity compensation plans approved by stockholders
|
|
10,338,100
|
(1)
|
$45
|
|
5,778,900
|
(2)
|
|
|
|
|
|
|
|
|
Equity compensation plans not approved by stockholders
|
|
--
|
|
--
|
|
--
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
TOTAL
|
|
10,338,100
|
|
$45
|
|
5,778,900
|
|
|
|
|
136 |
||
|
||
|
|
|
|
|
Page
|
(a)
|
1.
|
Consolidated Financial Statements:
|
|
79
|
|
|
|
|
|
|
|
Management's Responsibility for Financial Statements
|
|
80
|
|
|
|
|
|
|
|
Report of Independent Auditors
|
|
81
|
|
|
|
|
|
|
|
Consolidated Statements of Earnings (Loss), Comprehensive Income (Loss), and Retained Earnings
|
|
82
|
|
|
|
|
|
|
|
Consolidated Statements of Financial Position
|
|
83
|
|
|
|
|
|
|
|
Consolidated Statements of Cash Flows
|
|
84
|
|
|
|
|
|
|
|
Notes to Companys Consolidated Financial Statements
|
|
85-133
|
|
|
|
|
|
|
2.
|
Financial Statement Schedule
|
|
|
|
|
II - Valuation and Qualifying Accounts
|
|
145
|
|
|
|
|
|
|
3.
|
Exhibits filed as part of this report are listed in the Exhibit Index beginning at page 140
|
|
|
|
|
|
|
|
(b)
|
Reports on Form 8-K during fourth quarter 2003
|
|
|
|
|
|
|
|
|
|
On October 9, 2003, the Company furnished under Item 12 of Form 8-K the text of its public release updating efforts to improve CASPI segment profitability and disclosing expected results of operations for the third quarter of 2003.
On October 23, 2003, the Company furnished under Item 12 of Form 8-K the text of its public release of financial results for the third quarter of 2003.
On December 5, 2003, the Company filed under Item 5 of Form 8-K the
Agreement of Substitution and Amendment of Stockholder Protection Rights Agreement, dated as of April 23, 2003, and the amendment, dated as of December 4, 2003, to the Stockholder Protection Rights Agreement, dated as of December 13, 1993
.
|
|
|
|
|
|
|
|
|
(c)
|
The Exhibit Index and required Exhibits to this report are included beginning at page 140
|
|
|
|
|
|
|
|
|
(d)
|
II - Valuation and Qualifying Accounts
|
|
145
|
137 |
||
|
||
|
|
Eastman Chemical Company
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ J. Brian Ferguson
|
|
|
||
|
J. Brian Ferguson
|
|
|
Chairman of the Board and Chief Executive Officer
|
|
|
|
|
Date:
|
March 5, 2004
|
|
SIGNATURE
|
|
TITLE
|
|
DATE
|
|
|
|
||
|
|
|
|
|
PRINCIPAL EXECUTIVE OFFICER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ J. Brian Ferguson
|
|
Chairman of the Board of Directors
|
|
March 5, 2004
|
|
||||
J. Brian Ferguson
|
|
and Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRINCIPAL FINANCIAL OFFICER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Richard A. Lorraine
|
|
Senior Vice President and
|
|
March 5, 2004
|
|
||||
Richard A. Lorraine
|
|
Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRINCIPAL ACCOUNTING OFFICER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Curtis E. Espeland
|
|
Controller
|
|
March 5, 2004
|
|
||||
Curtis E. Espeland
|
|
|
|
|
|
|
|
|
|
138 |
||
|
||
|
SIGNATURE
|
|
TITLE
|
|
DATE
|
|
|
|
||
|
|
|
|
|
DIRECTORS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ H. Jesse Arnelle
|
|
Director
|
|
March 5, 2004
|
|
||||
H. Jesse Arnelle
|
|
|
|
|
|
|
|
|
|
/s/ Calvin A. Campbell, Jr.
|
|
Director
|
|
March 5. 2004
|
|
||||
Calvin A. Campbell, Jr.
|
|
|
|
|
|
|
|
|
|
/s/ Stephen R. Demeritt
|
|
Director
|
|
March 5, 2004
|
|
||||
Stephen R. Demeritt
|
|
|
|
|
|
|
|
|
|
/s/ Donald W. Griffin
|
|
Director
|
|
March 5, 2004
|
|
||||
Donald W. Griffin
|
|
|
|
|
|
|
|
|
|
/s/ Robert M. Hernandez
|
|
Director
|
|
March 5, 2004
|
|
||||
Robert M. Hernandez
|
|
|
|
|
|
|
|
|
|
/s/ Renee J. Hornbaker
|
|
Director
|
|
March 5, 2004
|
|
||||
Renee J. Hornbaker
|
|
|
|
|
|
|
|
|
|
/s/ Thomas H. McLain
|
|
Director
|
|
March 5, 2004
|
|
||||
Thomas H. McLain
|
|
|
|
|
|
|
|
|
|
/s/ David W. Raisbeck
|
|
Director
|
|
March 5, 2004
|
|
||||
David W. Raisbeck
|
|
|
|
|
|
|
|
|
|
/s/ John A. White
|
|
Director
|
|
March 5, 2004
|
|
||||
John A. White
|
|
|
|
|
|
|
|
|
|
/s/ Peter M. Wood
|
|
Director
|
|
March 5, 2004
|
|
||||
|
|
|
|
139 |
||
|
||
|
|
|
|
|
|
|
|
EXHIBIT INDEX
|
|
Sequential
|
Exhibit
|
|
|
|
Page
|
Number
|
|
Description
|
|
Number
|
|
|
|
||
|
|
|
|
|
3.01
|
|
Amended and Restated Certificate of Incorporation of Eastman Chemical Company, as amended (incorporated by reference to Exhibit 3.01 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2001)
|
|
|
|
|
|
|
|
3.02
|
|
Amended and Restated Bylaws of Eastman Chemical Company, as amended December 4, 2003
|
|
146-161
|
|
|
|
|
|
4.01
|
|
Form of Eastman Chemical Company Common Stock certificate as amended February 1, 2001 (incorporated herein by reference to Exhibit 4.01 to Eastman Chemical Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2001 (the "March 31, 2001 10-Q"))
|
|
|
|
|
|
|
|
4.02
|
|
Stockholder Protection Rights Agreement dated as of December 13, 1993, between Eastman Chemical Company and First Chicago Trust Company of New York, as Rights Agent (incorporated herein by reference to Exhibit 4.4 to Eastman Chemical Company's Registration Statement on Form S-8 relating to the Eastman Investment Plan, File No. 33-73810)
|
|
|
|
|
|
|
|
4.03
|
|
Indenture, dated as of January 10, 1994, between Eastman Chemical Company and The Bank of New York, as Trustee (the "Indenture") (incorporated herein by reference to Exhibit 4(a) to Eastman Chemical Company's current report on Form 8-K dated January 10, 1994 (the "8-K"))
|
|
|
|
|
|
|
|
4.04
|
|
Form of 6 3/8% Notes due January 15, 2004 (incorporated herein by reference to Exhibit 4(c) to the 8-K)
|
|
|
|
|
|
|
|
4.05
|
|
Form of 7 1/4% Debentures due January 15, 2024 (incorporated herein by reference to Exhibit 4(d) to the 8-K)
|
|
|
|
|
|
|
|
4.06
|
|
Officers Certificate pursuant to Sections 201 and 301 of the Indenture (incorporated herein by reference to Exhibit 4(a) to Eastman Chemical Company's Current Report on Form 8-K dated June 8, 1994 (the "June 8-K"))
|
|
|
|
|
|
|
|
4.07
|
|
Form of 7 5/8% Debentures due June 15, 2024 (incorporated herein by reference to Exhibit 4(b) to the June 8-K)
|
|
|
|
|
|
|
|
4.08
|
|
Form of 7.60% Debentures due February 1, 2027 (incorporated herein by reference to Exhibit 4.08 to Eastman Chemical Company's Annual Report on Form 10-K for the year ended December 31, 1996 (the "1996 10-K"))
|
|
|
|
|
|
|
|
4.09
|
|
Form of 7% Notes due April 15, 2012 (incorporated herein by reference to Exhibit 4.09 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2002)
|
|
|
|
|
|
|
|
4.10
|
|
Officer's Certificate pursuant to Sections 201 and 301 of the Indenture related to 7.60% Debentures due February 1, 2027 (incorporated herein by reference to Exhibit 4.09 to the 1996 10-K)
|
|
|
140 |
||
|
||
|
|
|
|
|
|
|
|
EXHIBIT INDEX
|
|
Sequential
|
Exhibit
|
|
|
|
Page
|
Number
|
|
Description
|
|
Number
|
|
|
|
||
|
|
|
|
|
4.11
|
|
$200,000,000 Accounts Receivable Securitization agreement dated April 13, 1999 (amended April 11, 2000), between the Company and Bank One, N.A., as agent. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, in lieu of filing a copy of such agreement, the Company agrees to furnish a copy of such agreement to the Commission upon request.
|
|
|
|
|
|
|
|
4.12
|
|
Credit Agreement, dated as of July 13, 2000 (the "Credit Agreement") among Eastman Chemical Company, the Lenders named therein, and Citibank, N.A. as Agent (incorporated herein by reference to Exhibit 4.11 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ending June 30, 2000)
|
|
|
|
|
|
|
|
4.13
|
|
Form of 3 ¼% Notes due June 16, 2008 (incorporated herein by reference to Exhibit 4.13 to Eastman Chemical Companys Quarterly Report on Form 10-Q for the quarter ending June 30, 2003)
|
|
|
|
|
|
|
|
4.14
|
|
Form of 6.30% notes due 2018 (incorporated herein by reference to Exhibit 4.14 to Eastman Chemical Companys Quarterly Report on Form 10-Q for the quarter ending September 30, 2003)
|
|
|
|
|
|
|
|
4.15
|
|
Amendments to Stockholder Protection Rights Agreement (incorporated herein by reference to Exhibits 4.1 and 4.2 to Eastman Chemical Companys current report on Form 8-K dated December 4, 2003).
|
|
|
|
|
|
|
|
10.01*
|
|
Eastman Chemical Company Benefit Security Trust dated January 2, 2002 (incorporated herein by reference to Exhibit 10.04 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)
|
|
|
|
|
|
|
|
10.02*
|
|
Amended Eastman Performance Plan (incorporated herein by referenced to Exhibit 10.02 to Eastman Chemical Companys Annual Report on Form 10-K for the year ended December 31, 2002, as initially filed on March 12, 2003.)
|
|
|
|
|
|
|
|
10.03*
|
|
2002 Director Long-Term Compensation Plan, as amended (incorporated herein by reference to Appendix A to Eastman Chemical Companys definitive 2002 Annual Meeting Proxy Statement filed pursuant to Regulation 14A)
|
|
|
|
|
|
|
|
10.04*
|
|
Eastman 2001-2003 Long-Term Performance Subplan of 1997 Omnibus Long-Term Compensation Plan (incorporated herein by reference to Exhibit 10.03 to the June 30, 2001 10-Q)
|
|
|
|
|
|
|
|
10.05*
|
|
Amended Eastman Executive Deferred Compensation Plan (incorporated herein by referenced to Exhibit 10.02 to Eastman Chemical Companys Annual Report on Form 10-K for the year ended December 31, 2002, as initially filed on March 12, 2003.)
|
|
|
|
|
|
|
|
10.06*
|
|
Eastman Excess Retirement Income Plan, amended and restated effective January 1, 2002 (incorporated herein by reference to Exhibit 10.10 to Eastman Chemical Company's Annual Report on Form 10-K for the year ended December 31, 2001, as initially filed on March 12, 2002.)
|
|
|
141 |
||
|
||
|
|
|
|
|
|
|
|
EXHIBIT INDEX
|
|
Sequential
|
Exhibit
|
|
|
|
Page
|
Number
|
|
Description
|
|
Number
|
|
|
|
||
|
|
|
|
|
10.14*
|
|
Eastman 2000-2002 Long-Term Performance Subplan of 1997 Omnibus Long-Term Compensation Plan (incorporated herein by reference to Exhibit 10.20 to Eastman Chemical Company's Annual Report on Form 10-K for the year ended December 31, 1999 (the "1999 10-K"))
|
|
|
|
|
|
|
|
10.15*
|
|
Form of Award Notice for Stock Options Granted to Managers under Omnibus Long-Term Compensation Plan (incorporated herein by reference to Exhibit 10.21 to the 1999 10-K)
|
|
|
|
|
|
|
|
10.16*
|
|
Form of Indemnification Agreements between Theresa K. Lee, Gregory O. Nelson, James P. Rogers and Eastman Chemical for service as directors of Genencor International, Inc. (incorporated herein by reference to Exhibit 10.01 to the June 30, 2000 10-Q)
|
|
|
142 |
||
|
||
|
|
|
|
|
|
|
|
EXHIBIT INDEX
|
|
Sequential
|
Exhibit
|
|
|
|
Page
|
Number
|
|
Description
|
|
Number
|
|
|
|
||
|
|
|
|
|
10.17
|
|
Imaging Chemicals License Agreement, dated as of December 31, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.13 to the S-1)
|
|
|
|
|
|
|
|
10.18
|
|
Contribution Agreement, dated as of December 9, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.07 to the S-1)
|
|
|
|
|
|
|
|
10.19
|
|
General Assignment, Assumption and Agreement Regarding Litigation, Claims and Other Liabilities, dated as of December 31, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.08 to the S-1)
|
|
|
|
|
|
|
|
10.20
|
|
Tax Sharing and Indemnification Agreement, dated as of December 31, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.09 to the S-1)
|
|
|
|
|
|
|
|
10.21
|
|
Intellectual Property Agreement Non-Imaging, dated as of December 31, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.12 to the S-1)
|
|
|
|
|
|
|
|
10.22*
|
|
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated October 7, 2002 (incorporated herein by reference to Exhibit 10.01 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)
|
|
|
|
|
|
|
|
10.23*
|
|
Amended and Restated Warrant to Purchase Shares of Common Stock of Eastman Chemical Company, dated January 2, 2002 (incorporated herein by reference to Exhibit 10.02 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)
|
|
|
|
|
|
|
|
10.24*
|
|
Amended and Restated Registration Rights Agreement, dated January 2, 2002 (incorporated herein by reference to Exhibit 10.03 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)
|
|
|
|
|
|
|
|
10.25*
|
|
Form of Indemnification Agreements with Directors and Executive Officers
|
|
168-186
|
|
|
|
|
|
10.26*
|
|
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated February 5, 2004
|
|
187-188
|
|
|
|
|
|
10.27*
|
|
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated January 1, 2004
|
|
189-191
|
143 |
||
|
||
|
|
|
|
|
|
|
|
EXHIBIT INDEX
|
|
Sequential
|
Exhibit
|
|
|
|
Page
|
Number
|
|
Description
|
|
Number
|
|
|
|
||
|
|
|
|
|
10.28*
|
|
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated January 1, 2004
|
|
192-194
|
|
|
|
|
|
10.29*
|
|
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated December 3, 2003
|
|
195-196
|
|
|
|
|
|
10.30*
|
|
Notice of Performance Shares Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated January 1, 2004
|
|
197-200
|
|
|
|
|
|
10.31*
|
|
Notice of Performance Shares Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated January 1, 2004
|
|
201-203
|
|
|
|
|
|
10.32*
|
|
Eastman 2004-2005 Performance Share Award Subplan of the 2002 Omnibus Long-Term Compensation Plan
|
|
204-213
|
|
|
|
|
|
10.33*
|
|
Eastman 2004-2006 Performance Share Award Subplan of the 2002 Omnibus Long-Term Compensation Plan
|
|
214-223
|
|
|
|
|
|
12.01
|
|
Statement re: Computation of Ratios of Earnings (Loss) to Fixed Charges
|
|
224
|
|
|
|
|
|
21.01
|
|
Subsidiaries of the Company
|
|
225-229
|
|
|
|
|
|
23.01
|
|
Consent of Independent Accountants
|
|
230
|
|
|
|
|
|
31.01
|
|
Rule 13a 14(a) Certification by J. Brian Ferguson, Chairman of the Board and Chief Executive Officer, for the year ended December 31, 2003
|
|
231
|
|
|
|
|
|
31.02
|
|
Rule 13a 14(a) Certification by Richard A. Lorraine, Senior Vice President and Chief Financial Officer, for the year ended December 31, 2003
|
|
232
|
|
|
|
|
|
32.01
|
|
Section 1350 Certification by J. Brian Ferguson, Chairman of the Board and Chief Executive Officer, for the year ended December 31, 2003
|
|
233
|
|
|
|
|
|
32.02
|
|
Section 1350 Certification by Richard A. Lorraine, Senior Vice President and Chief Financial Officer, for the year ended December 31, 2003
|
|
234
|
|
|
|
|
|
|
|
|
|
|
144 |
||
|
||
|
145
|
||
Exhibit 3.02
|
146
|
||
|
||
Exhibit 3.02
|
147
|
||
|
||
Exhibit 3.02
|
148
|
||
|
||
Exhibit 3.02
|
149
|
||
|
||
Exhibit 3.02
|
150
|
||
|
||
Exhibit 3.02
|
151 |
||
|
||
Exhibit 3.02
|
152
|
||
|
||
Exhibit 3.02
|
153
|
||
|
||
Exhibit 3.02
|
154
|
||
|
||
Exhibit 3.02
|
155
|
||
|
||
Exhibit 3.02
|
156
|
||
|
||
Exhibit 3.02
|
157
|
||
|
||
Exhibit 3.02
|
158
|
||
|
||
Exhibit 3.02
|
159
|
||
|
||
Exhibit 3.02
|
160
|
||
|
||
Exhibit 3.02
|
161
|
||
Exhibit 10.09
|
162 |
||
|
||
Exhibit 10.09
|
Quarter
|
Date of Promotion
|
Prorated Percent of Target UPP Variable Pay Allocated to Unit Award Pool
|
|
|
|
1st
|
January 1 - March 31
|
100%
|
|
|
|
2nd
|
April 1 - June 30
|
75%
|
|
|
|
3rd
|
July 1 - September 30
|
50%
|
|
|
|
4th
|
October 1 - December 31
|
25%
|
|
|
|
163 |
||
|
||
Exhibit 10.09
|
Quarter
|
Date of Change in UPP participation level
|
Percent of Target UPP Variable Pay Prior to Change Allocated to Unit Award Pool
|
Percent of New Target UPP Variable Pay After the Change Allocated to Unit Award Pool
|
|
|
|
|
1st
|
January 1 - March 31
|
0%
|
100%
|
|
|
|
|
2nd
|
April 1 - June 30
|
25%
|
75%
|
|
|
|
|
3rd
|
July 1 - September 30
|
50%
|
50%
|
|
|
|
|
4th
|
October 1 - December 31
|
75%
|
25%
|
|
|
|
|
Quarter
|
Date of Termination
|
Prorated Percent of Target UPP Variable Pay Allocated to Unit Award Pool
|
|
|
|
1st
|
January 1 - March 31
|
25%
|
|
|
|
2nd
|
April 1 - June 30
|
50%
|
|
|
|
3rd
|
July 1 - September 30
|
75%
|
|
|
|
4th
|
October 1 - December 31
|
100%
|
|
|
|
164 |
||
|
||
Exhibit 10.09
|
165 |
||
|
||
Exhibit 10.09
|
166 |
||
|
||
Exhibit 10.09
|
167 |
Exhibit 10.25
|
168 |
||
|
||
Exhibit 10.25
|
169 |
||
|
||
Exhibit 10.25
|
170 |
||
|
||
Exhibit 10.25
|
171 |
||
|
||
Exhibit 10.25
|
172 |
||
|
||
Exhibit 10.25
|
173 |
||
|
||
Exhibit 10.25
|
174 |
||
|
||
Exhibit 10.25
|
175 |
||
|
||
Exhibit 10.25
|
176 |
||
|
||
Exhibit 10.25
|
177 |
||
|
||
Exhibit 10.25
|
178 |
||
|
||
Exhibit 10.25
|
179 |
||
|
||
Exhibit 10.25
|
(a) Notwithstanding any other provision hereof, in making any Standard of Conduct Determination, the Person making such determination shall presume that Indemnitee has satisfied the applicable standard of conduct, and the Company may overcome such presumption only by its adducing clear and convincing evidence to the contrary. Any Standard of Conduct Determination that is adverse to Indemnitee may be challenged by the Indemnitee in the Court of Chancery of the State of Delaware. No determination by the Company (including by its directors or any Independent Counsel) that Indemnitee has not satisfied any applicable standard of conduct shall be a defense to any Claim by Indemnitee for indemnification or reimbursement or advance payment of Expenses by the Company hereunder or create a presumption that Indemnitee has not met any applicable standard of conduct.
9. No Other Presumption. For purposes of this Agreement, the termination of any Claim by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere or its equivalent, will not create a presumption that Indemnitee did not meet any applicable standard of conduct or that indemnification hereunder is otherwise not permitted.
10. Non-Exclusivity. The rights of Indemnitee hereunder will be in addition to any other rights Indemnitee may have under the Constituent Documents, or the substantive laws of the Companys jurisdiction of incorporation, any other contract or otherwise (collectively, " Other Indemnity Provisions "); provided , however , that (a) to the extent that Indemnitee otherwise would have any greater right to indemnification under any Other Indemnity Provision, Indemnitee will without further action be deemed to have such greater right hereunder and (b) to the extent that any change is made to any Other Indemnity Provision which permits any greater right to indemnification than that provided under this Agreement as of the date hereof, Indemnitee will be deemed to have such greater right hereunder. The Company may not adopt any amendment to any of the Constituent Documents the effect of which would be to deny, diminish or encumber Indemnitees right to indemnification under this Agreement or any Other Indemnity Provision.
180 |
||
|
||
Exhibit 10.25
|
181 |
||
|
||
Exhibit 10.25
|
182 |
||
|
||
Exhibit 10.25
|
183 |
||
|
||
Exhibit 10.25
|
184 |
||
|
||
Exhibit 10.25
|
185 |
||
|
||
Exhibit 10.25
|
|
||
186 |
Exhibit 10.26
|
187 |
||
|
||
Exhibit 10.26
|
188 |
||
Exhibit 10.27
|
189 |
||
|
||
Exhibit 10.27
|
190 |
||
|
||
Exhibit 10.27
|
191
|
||
Exhibit 10.28
|
192 |
||
|
||
Exhibit 10.28
|
193 |
||
|
||
Exhibit 10.28
|
194
|
||
Exhibit 10.29
|
195 |
||
|
||
Exhibit 10.29
|
196
|
||
Exhibit 10.30
|
197 |
||
|
||
Exhibit 10.30
|
198 |
||
|
||
Exhibit 10.30
|
199 |
||
|
||
Exhibit 10.30
|
200
|
||
Exhibit 10.31
|
201 |
||
|
||
Exhibit 10.31
|
202 |
||
|
||
Exhibit 10.31
|
203
|
||
Exhibit 10.32
|
204
|
||
|
||
Exhibit 10.32
|
Section
|
Title
|
Page
|
|
|
|
Section 1.
|
Background
|
1
|
|
|
|
Section 2.
|
Definitions
|
1
|
|
|
|
Section 3.
|
Administration
|
2
|
|
|
|
Section 4.
|
Eligibility
|
3
|
|
|
|
Section 5.
|
Form of Awards
|
3
|
|
|
|
Section 6.
|
Size of Awards
|
3
|
|
|
|
Section 7.
|
Composition of Comparison Group
|
4
|
|
|
|
Section 8.
|
Preconditions to Receipt of an Award
|
4
|
|
|
|
Section 9.
|
Manner and Timing of Award Payments
|
5
|
|
|
|
Section 10.
|
No Rights as Stockholder
|
6
|
|
|
|
Section 11.
|
Application of Plan
|
6
|
|
|
|
Section 12.
|
Adjustment of Actual Grant Amount
|
6
|
|
|
|
Section 13.
|
Amendments
|
6
|
|
|
|
Exhibit A.
|
|
7
|
|
|
|
Exhibit B.
|
|
8
|
205
|
||
|
||
Exhibit 10.32
|
1 |
206 |
||
|
||
Exhibit 10.32
|
2 |
207 |
||
|
||
Exhibit 10.32
|
3 |
208 |
||
|
||
Exhibit 10.32
|
4 |
209 |
||
|
||
Exhibit 10.32
|
5 |
210 |
||
|
||
Exhibit 10.32
|
6 |
211
|
||
|
||
Exhibit 10.32
|
7 |
212 |
||
|
||
Exhibit 10.32
|
Eastman TSR Relative to Comparison Companies
|
Differential from Target Return on Capital
|
|||||||||
|
|
|||||||||
|
<-7%
|
-5% to
-7%
|
-3 to
-5%
|
-1 to
-3%
|
-1 to +1%
|
+1 to +3%
|
+3 to +5%
|
+5 to +7%
|
+7 to +10%
|
>10%
|
|
|
|
|
|
|
|
|
|
|
|
0-19%( 5
th
quintile)
|
0.0
|
0.0
|
0.0
|
0.0
|
0.6
|
0.8
|
1.0
|
1.3
|
1.6
|
1.9
|
|
|
|
|
|
|
|
|
|
|
|
20-39%(4
th
quintile)
|
0.0
|
0.0
|
0.0
|
0.4
|
0.8
|
1.0
|
1.3
|
1.6
|
1.9
|
2.2
|
|
|
|
|
|
|
|
|
|
|
|
40-59%(3
rd
quintile)
|
0.0
|
0.0
|
0.4
|
0.6
|
1.0
|
1.3
|
1.6
|
1.9
|
2.2
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
60-79%(2
nd
quintile)
|
0.0
|
0.4
|
0.6
|
1.0
|
1.3
|
1.6
|
1.9
|
2.2
|
2.5
|
2.8
|
|
|
|
|
|
|
|
|
|
|
|
80-99%(1
st
quintile)
|
0.0
|
0.6
|
0.8
|
1.3
|
1.6
|
1.9
|
2.2
|
2.5
|
2.8
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
8 |
213
|
||
Exhibit 10.33
|
214
|
||
|
||
Exhibit 10.33
|
Section
|
Title
|
Page
|
|
|
|
Section 1.
|
Background
|
1
|
|
|
|
Section 2.
|
Definitions
|
1
|
|
|
|
Section 3.
|
Administration
|
2
|
|
|
|
Section 4.
|
Eligibility
|
3
|
|
|
|
Section 5.
|
Form of Awards
|
3
|
|
|
|
Section 6.
|
Size of Awards
|
3
|
|
|
|
Section 7.
|
Composition of Comparison Group
|
4
|
|
|
|
Section 8.
|
Preconditions to Receipt of an Award
|
4
|
|
|
|
Section 9.
|
Manner and Timing of Award Payments
|
5
|
|
|
|
Section 10.
|
No Rights as Stockholder
|
6
|
|
|
|
Section 11.
|
Application of Plan
|
6
|
|
|
|
Section 12.
|
Adjustment of Actual Grant Amount
|
6
|
|
|
|
Section 13.
|
Amendments
|
6
|
|
|
|
Exhibit A.
|
|
7
|
|
|
|
Exhibit B.
|
|
8
|
215
|
||
|
||
Exhibit 10.33
|
1 |
216 |
||
|
||
Exhibit 10.33
|
2 |
217 |
||
|
||
Exhibit 10.33
|
3 |
218 |
||
|
||
Exhibit 10.33
|
4 |
219 |
||
|
||
Exhibit 10.33
|
5 |
220 |
||
|
||
Exhibit 10.33
|
6 |
221
|
||
|
||
Exhibit 10.33
|
7 |
222 |
||
|
||
Exhibit 10.33
|
Eastman TSR Relative to Comparison Companies
|
Differential from Target Return on Capital
|
|||||||||
|
|
|||||||||
|
<-7%
|
-5% to
-7%
|
-3 to
-5%
|
-1 to
-3%
|
-1 to +1%
|
+1 to +3%
|
+3 to +5%
|
+5 to +7%
|
+7 to +10%
|
>10%
|
|
|
|
|
|
|
|
|
|
|
|
0-19%( 5
th
quintile)
|
0.0
|
0.0
|
0.0
|
0.0
|
0.6
|
0.8
|
1.0
|
1.3
|
1.6
|
1.9
|
|
|
|
|
|
|
|
|
|
|
|
20-39%(4
th
quintile)
|
0.0
|
0.0
|
0.0
|
0.4
|
0.8
|
1.0
|
1.3
|
1.6
|
1.9
|
2.2
|
|
|
|
|
|
|
|
|
|
|
|
40-59%(3
rd
quintile)
|
0.0
|
0.0
|
0.4
|
0.6
|
1.0
|
1.3
|
1.6
|
1.9
|
2.2
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
60-79%(2
nd
quintile)
|
0.0
|
0.4
|
0.6
|
1.0
|
1.3
|
1.6
|
1.9
|
2.2
|
2.5
|
2.8
|
|
|
|
|
|
|
|
|
|
|
|
80-99%(1
st
quintile)
|
0.0
|
0.6
|
0.8
|
1.3
|
1.6
|
1.9
|
2.2
|
2.5
|
2.8
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
8 |
223
|
||
Dollars in millions)
|
|
2003
|
|
2002
|
|
2001
|
|
2000
|
|
1999
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) before income taxes and cumulative effect of change in accounting principle
|
$
|
(381)
|
$
|
84
|
$
|
(291)
|
$
|
452
|
$
|
72
|
Add:
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
130
|
|
128
|
|
146
|
|
142
|
|
126
|
Appropriate portion of rental expense
(1)
|
|
21
|
|
28
|
|
28
|
|
28
|
|
28
|
Amortization of capitalized interest
|
|
12
|
|
13
|
|
15
|
|
15
|
|
16
|
|
|
|
|
|
||||||
Earnings (loss) as adjusted
|
$
|
(218)
|
$
|
253
|
$
|
(102)
|
$
|
637
|
$
|
242
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
Fixed charges:
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
$
|
130
|
$
|
128
|
$
|
146
|
$
|
142
|
$
|
126
|
Appropriate portion of rental expense (1)
|
|
21
|
|
28
|
|
28
|
|
28
|
|
28
|
Capitalized interest
|
|
3
|
|
4
|
|
5
|
|
6
|
|
13
|
|
|
|
|
|
||||||
Total fixed charges
|
$
|
154
|
$
|
160
|
$
|
179
|
$
|
176
|
$
|
167
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
Ratio of earnings (loss) to fixed charges
|
|
(B)
|
|
1.6x
|
|
(A)
|
|
3.6x
|
|
1.5x
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) Due to the net loss reported, the coverage ratio was less than 1x. To achieve a coverage ratio of 1x, additional pre-tax earnings of $281 million would have been required for 2001.
(B) Due to the net loss reported, the coverage ratio was less than 1x. To achieve a coverage ratio of 1x, additional pre-tax earnings of $372 million would have been required for 2003.
224 |
EXHIBIT 21.01
|
|
JURISDICTION OF
|
|
INCORPORATION
|
NAME OF SUBSIDIARY
|
OR ORGANIZATION
|
|
|
Altovar Ltd.
|
United Kingdom
|
Air Products Liquid Phase Conversion Company, L.P
|
Delaware
|
Ariel Research Corporation
|
Delaware
|
Ariel Research Corporation Europe ApS
|
Denmark
|
Cendian Corporation
|
Delaware
|
Diagnostics Acquisition Corp.
|
Delaware
|
Eastman (Shanghai) Chemical Trading Co., Ltd.
|
China
|
Eastman (Tianjin) Chemical Company
|
China
|
Eastman Belgium B.V.B.A.
|
Belgium (Kallo)
|
Eastman Cayman Financial Services Limited
|
Cayman Islands
|
Eastman Chemical (Malaysia) Sdn. Bhd.
|
Malaysia
|
Eastman Chemical Asia Pacific Pte. Ltd.
|
Singapore
|
Eastman Chemical B.V.
|
Netherlands
|
Eastman Chemical Canada, Inc.
|
Canada
|
Eastman Chemical Company Foundation, Inc.
|
Delaware
|
Eastman Chemical Company Investments, Inc.
|
Delaware
|
Eastman Chemical Deutschland GmbH
|
Germany
|
Eastman Chemical Espana, Inc.
|
Delaware
|
Eastman Chemical, Europe, Middle East, and Africa, Ltd.
|
Delaware
|
Eastman Chemical Financial Corporation
|
Delaware
|
225 |
||
|
||
EXHIBIT 21.01
|
|
JURISDICTION OF
|
|
INCORPORATION
|
NAME OF SUBSIDIARY
|
OR ORGANIZATION
|
|
|
Eastman Chemical Finland Oy
|
Finland
|
Eastman Chemical GmbH & Co KG
|
Germany
|
Eastman Chemical Holding GmbH
|
Germany
|
Eastman Chemical Holdings, S.A. de C.V.
|
Mexico
|
Eastman Chemical Hong Kong Limited
|
Hong Kong
|
Eastman Chemical Italia S.r.l.
|
Italy
|
Eastman Chemical Japan Limited
|
Japan
|
Eastman Chemical Korea Ltd.
|
Korea
|
Eastman Chemical Latin America, Inc.
|
Delaware
|
Eastman Chemical Ltd.
|
New York
|
Eastman Chemical Luxembourg S.a.r.l.
|
Luxembourg
|
Eastman Chemical Middelburg, B.V.
|
Netherlands
|
Eastman Chemical Resins, Inc.
|
Delaware
|
Eastman Chemical Singapore Pte. Ltd.
|
Singapore
|
Eastman Chemical Sweden AB
|
Sweden
|
Eastman Chemical The Hague B.V.
|
Netherlands
|
Eastman Chemical Uruapan, S.A. de C.V.
|
Mexico
|
Eastman Cogen Management L.L.C.
|
Texas
|
Eastman Cogeneration L.P.
|
Texas
|
226 |
||
|
||
EXHIBIT 21.0
1
|
|
JURISDICTION OF
|
|
INCORPORATION
|
NAME OF SUBSIDIARY
|
OR ORGANIZATION
|
|
|
Eastman Company
|
Delaware
|
Eastman Company UK Limited
|
United Kingdom
|
Eastman do Brasil Ltda.
|
Brazil
|
Eastman Espana S. L.
|
Spain
|
Eastman Gasification Services Company
|
Delaware
|
Eastman International Management Company
|
Tennessee
|
Eastman Malta Limited
|
Malta
|
Eastman Netherlands B.V.
|
Netherlands
|
Eastman Resins, Inc.
|
Delaware
|
Eastman Servicios Corporativos, S.A. de C.V.
|
Mexico
|
Eastman Sokolov, a.s.
|
Czech Republic
|
Enterprise Genetics, Inc.
|
Nevada
|
Fujian Nanping Eastman Company
|
China
|
GLC Associates
|
Nevada
|
Hartlepet Limited
|
United Kingdom
|
Holston Defense Corporation
|
Virginia
|
Industrias Voridian, S.A. de C.V.
|
Mexico
|
Jager Chemie France S.A.R.L.
|
France
|
Jager Chemie i.L., Basel
|
Switzerland
|
227 |
||
|
||
EXHIBIT 21.01
|
|
JURISDICTION OF
|
|
INCORPORATION
|
NAME OF SUBSIDIARY
|
OR ORGANIZATION
|
|
|
Jager Verwaltungs-GmbH
|
Germany
|
Jiangsu Funing Eastman Chemical Co., Ltd.
|
China
|
Kingsport Hotel, L.L.C.
|
Tennessee
|
Lawter International (Canada) Company
|
Canada
|
Lawter International (Hong Kong) Limited
|
Hong Kong
|
Lawter International Products, Pte. Ltd.
|
Singapore
|
Lawter International, A.p.S
|
Denmark
|
Lawter International, B.V.B.A.
|
Belgium
|
Lawter International, S.A.
|
Spain
|
McWhorter Holdings AB
|
Sweden
|
McWhorter Holdings Ltd.
|
United Kingdom
|
Mustang Pipeline Company
|
Texas
|
Nanjing Yangzi Eastman Chemical Ltd.
|
China
|
Peroxides s.r.o.
|
Czech Republic
|
Pinto Pipeline Company of Texas
|
Texas
|
Primester
|
New York
|
Qilu Eastman Specialty Chemicals, Ltd
|
China
|
Shanghai Eastman Consulting Company Ltd
|
China
|
Union-Chemie Singapore Pte. Ltd.
|
Singapore
|
Voridian (Gibraltar) Limited
|
United Kingdom
|
228 |
||
|
||
EXHIBIT 21.01
|
|
JURISDICTION OF
|
|
INCORPORATION
|
NAME OF SUBSIDIARY
|
OR ORGANIZATION
|
|
|
Voridian (U.K.)
|
United Kingdom
|
Voridian AG
|
Switzerland
|
Voridian Argentina S.R.L.
|
Argentina
|
Voridian B.V.
|
Netherlands
|
Voridian Canada Company
|
Nova Scotia
|
Voridian Company
|
Delaware
|
Voridian de Mexico, S.A. de C.V.
|
Mexico
|
Voridian do Brasil Ltda.
|
Brazil - partnership
|
Voridian England Ltd.
|
United Kingdom
|
Voridian Espana S.A.
|
Spain
|
Voridian Europoort B.V.
|
Netherlands
|
Voridian Holdings B.V.
|
Netherlands
|
Voridian Holdings S.L.
|
Spain
|
Voridian Hong Kong Limited
|
Hong Kong
|
Voridian International, Limited
|
United Kingdom
|
Voridian Polymer Ltd.
|
United Kingdom
|
Voridian Singapore Pte. Ltd.
|
Singapore
|
Voridian Spain L.L.C.
|
Delaware
|
Workington Investments Limited
|
United Kingdom
|
229
|
||
/s/ PricewaterhouseCoopers LLP
|
|
230
|
||
231
|
||
232
|
||
233
|
||
234
|
||